PT  - JOURNAL ARTICLE
AU  - Anderson, Mary
AU  - Hassell, Kathryn L.
AU  - Trujillo, Toby C.
AU  - Wolfe, Brian
TI  - When patients on target-specific oral anticoagulants need surgery
AID  - 10.3949/ccjm.81a.13168
DP  - 2014 Oct 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 629--639
VI  - 81
IP  - 10
4099  - http://www.ccjm.org/content/81/10/629.short
4100  - http://www.ccjm.org/content/81/10/629.full
SO  - Cleve Clin J Med2014 Oct 01; 81
AB  - The target-specific oral anticoagulants (TSOACs), eg, dabigatran, rivaroxaban, and apixaban, are changing the way we manage thromboembolic disease. At the same time, many clinicians wonder how best to manage TSOAC therapy when patients need surgery. An in-depth understanding of these drugs is essential to minimize the risk of bleeding and thrombosis perioperatively.